https://haemato.de/de/ https://haemato.de/de/arzneimittel.html https://haemato.de/de/schulungsmaterial.html https://haemato.de/de/eigenmarken.html https://haemato.de/de/strategiefokus.html https://haemato.de/de/unternehmen.html https://haemato.de/de/karriere.html https://haemato.de/de/kontakt.html https://haemato.de/de/bestellservice.html https://haemato.de/de/msv3.html https://haemato.de/de/agb.html https://haemato.de/de/impressum.html https://haemato.de/de/datenschutz.html https://haemato.de/de/datenschutzhinweise-zoom.html https://haemato.de/de/cookies.html https://haemato.de/de/haftungsausschluss.html https://haemato.de/de/sitemap.html https://haemato.de/de/suche.html https://haemato.de/en/start.html https://haemato.de/en/pharmaceuticals.html https://haemato.de/en/educational-material.html https://haemato.de/en/own-brands.html https://haemato.de/en/strategy-focus.html https://haemato.de/en/company.html https://haemato.de/en/career-perspective.html https://haemato.de/en/details-en.html https://haemato.de/en/general-meeting.html https://haemato.de/en/contact.html https://haemato.de/en/terms-of-service.html https://haemato.de/en/legal-notice.html https://haemato.de/en/data-protection.html https://haemato.de/en/cookies-2.html https://haemato.de/en/disclaimer.html https://haemato.de/en/sitemap-2.html https://haemato.de/en/search.html https://haemato.de/en/details-en/cancellation-of-listing.html https://haemato.de/en/details-en/q3-2023-results.html https://haemato.de/en/details-en/termination-of-the-botulinum-toxin-project.html https://haemato.de/en/details-en/haemato-ag-publishes-figures-for-the-first-half-of-2023.html https://haemato.de/en/details-en/q1-2023-results.html https://haemato.de/en/details-en/dividend-of-eur-1-20.html https://haemato.de/en/details-en/haemato-ag-publishes-preliminary-figures-for-the-2022-financial-year.html https://haemato.de/en/details-en/q3-2022-results.html https://haemato.de/en/details-en/haemato-ag-publishes-figures-for-q2-2022.html https://haemato.de/en/details-en/q1-2022-results.html https://haemato.de/en/details-en/dividend-of-eur-1-10.html https://haemato.de/en/details-en/haemato-ag-publishes-preliminary-figures-for-the-2021-financial-year.html https://haemato.de/en/details-en/expansion-of-the-executive-board-of-haemato-ag-strengthening-operational-excellence.html https://haemato.de/en/details-en/haemato-adds-a-new-generation-test-device-to-its-portfolio.html https://haemato.de/en/details-en/haemato-distributes-pcr-point-of-care-devices.html https://haemato.de/en/details-en/gbc-board-interview-with-patrick-brenske-ceo-of-haemato-ag.html https://haemato.de/en/details-en/q3-2021-results.html https://haemato.de/en/details-en/haemato-seeks-marketing-authorization-and-plans-distribution-of-a-botulinum-toxin-product-under-its-own-brand-in-europe.html https://haemato.de/en/details-en/haemato-seeks-marketing-authorization-and-plans-distribution-of-a-botulinum-toxin-product-under-its-own-brand-in-europe-2.html https://haemato.de/en/details-en/preliminary-figures-q2-2021.html https://haemato.de/en/details-en/q1-2021-results.html https://haemato.de/en/details-en/haemato-ag-proposes-dividend-payment.html https://haemato.de/en/details-en/according-to-the-preliminary-ifrs-financial-statements-for-the-2020-financial-year-haemato-ag-increased-its-revenue-by-20-5-to-eur-238-3-million-and-increased-ebitda-by-74-8-to-eur-3-3-million.html https://haemato.de/en/details-en/haemato-ag-successfully-completes-capital-increase.html https://haemato.de/en/details-en/haemato-ag-plans-cash-capital-increase-to-finance-private-label-business.html https://haemato.de/en/details-en/haemato-pharm-gmbh-as-a-subsidiary-of-haemato-ag-receives-a-special-approval.html https://haemato.de/en/details-en/212049-2.html https://haemato.de/en/details-en/212002-2.html https://haemato.de/en/details-en/211971-2.html https://haemato.de/en/details-en/notification-concerning-ordinary-capital-reduction.html https://haemato.de/en/details-en/half-year-report-2020.html https://haemato.de/en/details-en/ad-hoc-disclosure-25-06-2020.html https://haemato.de/en/details-en/ad-hoc-disclosure-under-art-17-mar.html https://haemato.de/en/details-en/agm-postponement.html https://haemato.de/en/details-en/q1-2020-results.html https://haemato.de/en/details-en/annual-report-2019.html https://haemato.de/en/details-en/211493-2.html https://haemato.de/en/details-en/haemato-ag-corporate-news-preliminary-ifrs-results-2019.html https://haemato.de/en/details-en/ifrs-third-quarter-2019-results.html https://haemato.de/en/details-en/interim-report-2019.html https://haemato.de/en/details-en/results-q1-2019.html https://haemato.de/en/details-en/annual-report-2018.html https://haemato.de/en/details-en/2018-preliminary-ifrs-results.html https://haemato.de/en/details-en/ifrs_third-quarter_2018_results.html https://haemato.de/en/details-en/half-year-report-2018.html https://haemato.de/en/details-en/annual-general-meeting-approves-agenda-items-with-a-large-majority.html https://haemato.de/en/details-en/haemato-ag-ifrs-results-q1-2018.html https://haemato.de/en/details-en/annual-report-2017.html https://haemato.de/en/details-en/2017-preliminary-ifrs-results.html https://haemato.de/en/details-en/ifrs-results-q3-2017.html https://haemato.de/en/details-en/interim-report-second-quarter-2017.html https://haemato.de/en/details-en/ad-hoc-news-from-07-07-2017.html https://haemato.de/en/details-en/210504-2.html https://haemato.de/en/details-en/210502-2.html https://haemato.de/en/details-en/210513-2.html